Arginine-rich, cell penetrating peptide-anti-microRNA complexes decrease glioblastoma migration potential

被引:29
作者
Zhang, Yu [1 ]
Koellmer, Melanie [1 ]
Buhrman, Jason S. [1 ]
Tang, Mary Y. [1 ]
Gemeinhart, Richard A. [1 ,2 ,3 ]
机构
[1] Univ Illinois, Dept Biopharmaceut Sci, Chicago, IL 60612 USA
[2] Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA
[3] Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL 60612 USA
关键词
miRNAs; miRNA-21; Glioblastoma; Anti-miRNAs; Cell penetrating peptide; HYDROGEL MATRICES; PLASMID DNA; DELIVERY; CANCER; MIR-21; INVASION; TARGETS; SIRNA; RNA; DIFFERENTIATION;
D O I
10.1016/j.peptides.2014.06.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
MicroRNAs (miRNAs) are a class of gene regulators originating from non-coding endogenous RNAs. Altered expression, both up- and down-regulation, of miRNAs plays important roles in many human diseases. Correcting miRNA dysregulation by either inhibiting or restoring miRNA function may provide therapeutic benefit. However, efficient, nontoxic miRNA delivery systems are in need. Cell penetrating peptides (CPPs) have been widely exploited for protein, DNA, and RNA delivery. Few have examined CPP transfection efficiency with single stranded anti-miRNA. The R-8 peptide condensed both siRNA and anti-miRNA. Greater than 50% of cells had anti-miRNA/R-8 complexes associated and in these cells 68% of anti-miRNA escapes the endosome/lysosome. Single-stranded antisense miR-21 inhibitor (anti-miR-21) administered using the R-8 peptide elicited efficient downstream gene upregulation. Glioblastoma cell migration was inhibited by 25% compared to the negative control group. To our knowledge, this is the first demonstration of miRNA modulation with anti-miR-21/R-8 complexes, which has laid the groundwork for further exploring octaarginine as intracellular anti-miRNAs carrier. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:83 / 90
页数:8
相关论文
共 51 条
[1]
Quantitative three-dimensional analysis of the intracellular trafficking of plasmid DNA transfected by a nonviral gene delivery system using confocal laser scanning microscopy [J].
Akita, H ;
Ito, R ;
Khalil, IA ;
Futaki, S ;
Harashima, H .
MOLECULAR THERAPY, 2004, 9 (03) :443-451
[2]
MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer [J].
Asangani, I. A. ;
Rasheed, S. A. K. ;
Nikolova, D. A. ;
Leupold, J. H. ;
Colburn, N. H. ;
Post, S. ;
Allgayer, H. .
ONCOGENE, 2008, 27 (15) :2128-2136
[3]
The Promise of MicroRNA Replacement Therapy [J].
Bader, Andreas G. ;
Brown, David ;
Winkler, Matthew .
CANCER RESEARCH, 2010, 70 (18) :7027-7030
[4]
The impact of microRNAs on protein output [J].
Baek, Daehyun ;
Villen, Judit ;
Shin, Chanseok ;
Camargo, Fernando D. ;
Gygi, Steven P. ;
Bartel, David P. .
NATURE, 2008, 455 (7209) :64-U38
[5]
MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[6]
Bhardwaj Arun, 2010, Mol Cell Pharmacol, V2, P213
[7]
A guided tour into subcellular colocalization analysis in light microscopy [J].
Bolte, S. ;
Cordelieres, F. P. .
JOURNAL OF MICROSCOPY, 2006, 224 (213-232) :213-232
[8]
Proteolytically activated anti-bacterial hydrogel microspheres [J].
Buhrman, Jason S. ;
Cook, Laura C. ;
Rayahin, Jamie E. ;
Federle, Michael J. ;
Gemeinhart, Richard A. .
JOURNAL OF CONTROLLED RELEASE, 2013, 171 (03) :288-295
[9]
MicroRNA signatures in human cancers [J].
Calin, George A. ;
Croce, Carlo M. .
NATURE REVIEWS CANCER, 2006, 6 (11) :857-866
[10]
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells [J].
Chan, JA ;
Krichevsky, AM ;
Kosik, KS .
CANCER RESEARCH, 2005, 65 (14) :6029-6033